Clinical Genomics Appoints Mark Boyle President, In Vitro Diagnostics
December 21, 2016 10:12 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the appointment of Mark...
Clinical Genomics Appoints Mark Boyle President, In Vitro Diagnostics
December 21, 2016 08:00 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the appointment of Mark...
Clinical Genomics Announces the Launch of Colvera™ for Colorectal Cancer Recurrence Monitoring
December 20, 2016 08:00 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Dec. 20, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the launch of Colvera™, a...
Clinical Genomics Announces Appointment of Michael Dugan, M.D. as Chief Medical Officer
November 14, 2016 08:00 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-driven diagnostic tools for colorectal cancer, today announced the appointment of...
Clinical Genomics Strengthens its Leadership Team with Multiple Key Appointments
October 13, 2016 08:00 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative healthcare solutions for cancer diagnosis, today announced the appointments of Laurie...
Data Published in Cancer Medicine Demonstrate Clinical Genomics’ Blood Test for Colorectal Cancer Recurrence is Two-Fold More Sensitive than CEA Test
October 12, 2016 08:00 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, today announced that data supporting its...
Clinical Genomics Celebrates Ten Years of Innovation
September 29, 2016 08:00 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, marks a decade of discovery and innovation as...
Clinical Genomics Announces Implementation of UNIConnect® Precision Molecular Diagnostics Laboratory Information Management System
June 02, 2016 07:30 ET
|
Clinical Genomics
BRIDGEWATER, N.J. and SALT LAKE CITY, June 02, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing advanced diagnostic tools for colorectal cancer, today announced that it has...
Clinical Genomics Announces Closing of $15 Million Series A Financing Round
March 23, 2016 07:00 ET
|
Clinical Genomics
Investment will support commercialization of company’s blood-based test for colorectal cancer recurrence Appoints Dr. Paul Kelly to board of directors EDISON, N.J., March 23, 2016 (GLOBE...
Clinical Genomics Presents Data Supporting Novel 2-Gene Blood Test for Earlier Detection of Colorectal Cancer Recurrence at ASCO GI
January 25, 2016 08:00 ET
|
Clinical Genomics
EDISON, N.J., Jan. 25, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing next-generation diagnostic tools for colorectal cancer, today announced new data supporting its 2-gene...